Halozyme Therapeutics, Inc. (HALO)

63.50 +1.30 (+2.08%) USD  |  NASDAQ  |  Dec 15, 16:00
63.40 -0.10 (-0.17%) After-Hours: 20:00
More

Halozyme Therapeutics EPS Basic from Continuing Operations (Quarterly)

EPS Basic from Continuing Operations (Quarterly) Chart

View EPS Basic from Continuing Operations (Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Basic from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Continuing Operations (Quarterly) Benchmarks

View EPS Basic from Continuing Operations (Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Johnson & Johnson Upgrade
AIM ImmunoTech, Inc. Upgrade